Patents by Inventor Steven Lenicek

Steven Lenicek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrroloquinolinone derivatives as 5-hydroxytryptamine-6 ligands
    Publication number: 20070099911
    Abstract: The present invention provides a compound of formula I and the use thereof in the therapeutic treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
    Type: Application
    Filed: October 27, 2006
    Publication date: May 3, 2007
    Applicant: Wyeth
    Inventors: Michael Kelly, Steven Lenicek, Yvette Palmer
  • 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands
    Publication number: 20060148831
    Abstract: The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.
    Type: Application
    Filed: March 3, 2006
    Publication date: July 6, 2006
    Applicant: Wyeth
    Inventors: Ronald Bernotas, Steven Lenicek, Schuyler Antane
  • 1-Heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
    Publication number: 20060142330
    Abstract: The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
    Type: Application
    Filed: February 15, 2006
    Publication date: June 29, 2006
    Applicant: Wyeth
    Inventors: Ronald Bernotas, Steven Lenicek, Hassan Elokdah, David Li
  • 1-Heterocyclylalkyl-3-sulfonylindole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
    Publication number: 20060030593
    Abstract: The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
    Type: Application
    Filed: September 29, 2005
    Publication date: February 9, 2006
    Applicant: Wyeth
    Inventors: Ronald Bernotas, Steven Lenicek
  • 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands
    Publication number: 20050085481
    Abstract: The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.
    Type: Application
    Filed: October 12, 2004
    Publication date: April 21, 2005
    Applicant: Wyeth
    Inventors: Ronald Bernotas, Steven Lenicek, Schuyler Antane
  • 3-Amino chroman and 2-amino tetralin derivatives
    Publication number: 20050032873
    Abstract: 3-Amino chroman and 2-amino tetralin derivatives and compositions containing such compounds are disclosed. Methods of using the 3-amino chroman and 2-amino tetralin compounds and compositions containing such compounds in the treatment of serotonin disorders, such as depression and anxiety, are also disclosed.
    Type: Application
    Filed: July 26, 2004
    Publication date: February 10, 2005
    Applicant: Wyeth
    Inventors: Nicole Hatzenbuhler, Deborah Evrard, Richard Mewshaw, Dahui Zhou, Uresh Shah, Jennifer Inghrim, Steven Lenicek, Reinhardt Baudy, John Butera, Annmarie Sabb, Amedeo Failli, Pudukkaraipudur Ramamoorthy